CLASS II HLA EPLET MISMATCH IS A RISK FACTOR FOR DE NOVO DONOR-SPECIFIC ANTIBODY DEVELOPMENT IN KIDNEY TRANSPLANTATION RECIPIENT

被引：0
|
作者：
Yamane, Hiroaki [1 ]
Tanaka, Yuka [1 ]
Ono, Kosuke [1 ]
Ohira, Masahiro [1 ]
Tahara, Hiroyuki [1 ]
Ide, Kentaro [1 ]
Ohdan, Hideki [1 ]
机构：
[1] Hiroshima Univ, Hiroshima, Japan
来源：
TRANSPLANT INTERNATIONAL | 2019年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
OS131
引用
收藏
页码：43 / 43
页数：1
相关论文
共 50 条
  • [1] Class II HLA Eplet Mismatch Is a Risk Factor for De Novo Donor-Specific Antibody Development and Antibody-mediated Rejection in Kidney Transplantation Recipients
    Kishikawa, H.
    Kinoshita, T.
    Hashimoto, M.
    Fukae, S.
    Taniguchi, A.
    Yamanaka, K.
    Nakagawa, M.
    Nishimura, K.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (08) : 2388 - 2391
  • [2] CLASS II HLA EPLET MISMATCH IS RELATED TO ANTI-DONOR CD4+T CELL RESPONSE AND DE NOVO DONOR-SPECIFIC ANTIBODY DEVELOPMENT IN KIDNEY TRANSPLANTATION RECIPIENT
    Tanaka, Hiroaki Yamane Yuka
    Ohira, Masahiro
    Tahara, Hiroyuki
    Ide, Kentaro
    Ohdan, Hideki
    TRANSPLANTATION, 2020, 104 (09) : S160 - S160
  • [3] Eplet mismatch scores and de novo donor-specific antibody development in simultaneous pancreas-kidney transplantation
    Ladowski, J. M.
    Mullins, Haddon
    Romine, Margaret
    Kloda, David
    Young, Carlton
    Hauptfeld-Dolejsek, Vera
    Houp, Julie
    Locke, Jayme
    HUMAN IMMUNOLOGY, 2021, 82 (03) : 139 - 146
  • [4] Impact of HLA Eplet Mismatch on De Novo Donor Specific Antibody Formation After Kidney Transplantation
    Yanyiam, Peerawit
    Kantachuvesiri, Surasak
    Thammanichanond, Duangtawan
    TRANSPLANTATION PROCEEDINGS, 2024, 56 (03) : 515 - 520
  • [5] Combined Analysis of HLA Class II Eplet Mismatch and Tacrolimus Levels for the Prediction of De Novo Donor Specific Antibody Development in Kidney Transplant Recipients
    Lee, Hyeyoung
    Min, Ji Won
    Kang, Hyunhye
    Lee, Hanbi
    Eum, Sang Hun
    Park, Yohan
    Yang, Chul Woo
    Ha Chung, Byung
    Oh, Eun-Jee
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (13)
  • [6] Eplet mismatches associated with de novo donor-specific HLA antibody in pediatric kidney transplant recipients
    Charnaya, Olga
    Jones, June
    Philogene, Mary Carmelle
    Chiang, Po-Yu
    Segev, Dorry L.
    Massie, Allan B.
    Garonzik-Wang, Jacqueline
    PEDIATRIC NEPHROLOGY, 2020, 36 (12) : 3971 - 3979
  • [7] Eplet mismatches associated with de novo donor-specific HLA antibody in pediatric kidney transplant recipients
    Olga Charnaya
    June Jones
    Mary Carmelle Philogene
    Po-Yu Chiang
    Dorry L. Segev
    Allan B. Massie
    Jacqueline Garonzik-Wang
    Pediatric Nephrology, 2021, 36 : 3971 - 3979
  • [8] IDENTIFICATION OF IMMUNOGENIC RECIPIENT HLA CLASS II AND DONOR-HLA-DERIVED PEPTIDE COMPLEXES: CLINICAL RELEVANCE TO DE NOVO DONOR-SPECIFIC HLA ANTIBODY FORMATION IN KIDNEY TRANSPLANTATION
    Tomosugi, Toshihide
    Iwasaki, Kenta
    Futamura, Kenta
    Okada, Manabu
    Hiramitsu, Takahisa
    Tsujita, Makoto
    Goto, Norihiko
    Narumi, Shunji
    Watarai, Yoshihiko
    Kobayashi, Takaaki
    Niemann, Matthias
    Spierings, Eric
    TRANSPLANT INTERNATIONAL, 2019, 32 : 88 - 88
  • [9] Correlation of immunogenicity of HLA-Class II eplet mismatches with the development of de novo donor-specific antibodies regarding patients after lung transplantation
    Kleid, Lisa
    Kauke, Teresa
    Dick, Andrea
    HLA, 2022, 99 (05) : 455 - 456
  • [10] Class II Eplet Mismatch Modulates Tacrolimus Trough Levels Required to Prevent Donor-Specific Antibody Development
    Wiebe, Chris
    Rush, David N.
    Nevins, Thomas E.
    Birk, Patricia E.
    Blydt-Hansen, Tom
    Gibson, Ian W.
    Goldberg, Aviva
    Ho, Julie
    Karpinski, Martin
    Pochinco, Denise
    Sharma, Atul
    Storsley, Leroy
    Matas, Arthur J.
    Nickerson, Peter W.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 28 (11): : 3353 - 3362
12345